Bryan Thacker is a scientist with extensive experience in bioanalytics, genomic engineering, and glycobiology. Currently serving as Scientist II CMC Bioanalytics at BioAgilytix since June 2022, Bryan leads the development and validation of bioassays such as ELISA and large molecule LCMS. Previously, at TEGA Therapeutics Inc, Bryan held the position of Senior Scientist, overseeing projects on mammalian metabolic pathways and analytical method development. Bryan's academic background includes a PhD in Biomedical Sciences and an MS in Bioengineering from UC San Diego, alongside a BS and BA from the University of Arizona in Mechanical Engineering and Biochemistry, respectively. Experience as a Doctoral Research Student at UC San Diego included developing chromatographic and proteomic techniques, while earlier roles involved practical research in organic chemistry and cryobiology.
This person is not in any teams
This person is not in any offices